Literature DB >> 19005073

Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand.

Martin B Wax1, Gülgün Tezel, Junjie Yang, Guanghua Peng, Rajkumar V Patil, Neeraj Agarwal, Rebecca M Sappington, David J Calkins.   

Abstract

Glaucomatous optic neuropathy causes blindness through the degeneration of retinal ganglion cells (RGCs) and their axons, which comprise the optic nerve. Glaucoma traditionally is associated with elevated intraocular pressure, but often occurs or may progress with intraocular pressure in the normal range. Like other diseases of the CNS, a subset of glaucoma has been proposed to involve an autoimmune component to help explain the loss of RGCs in the absence of elevated intraocular pressure. One hypothesis involves heat shock proteins (HSPs), because increased serum levels of HSP autoantibodies are prominent in some glaucoma patients with normal pressures. In the first direct support of this hypothesis, we found that HSP27 and HSP60 immunization in the Lewis rat induced RGC degeneration and axon loss 1-4 months later in vivo in a pattern with similarities to human glaucoma, including topographic specificity of cell loss. Infiltration of increased numbers of T-cells in the retina occurred much earlier, 14-21 d after HSP immunization, and appeared to be transient. In vitro studies found that T-cells activated by HSP immunization induced RGC apoptosis via the release of the inflammatory cytokine FasL, whereas HSP immunization induced activation of microglia cells and upregulation of the FasL receptor in RGCs. In summary, our results suggest that RGC degeneration in glaucoma for selected individuals likely involves failed immunoregulation of the T-cell-RGC axis and is thus a disturbance of both proapoptotic and protective pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005073      PMCID: PMC2683273          DOI: 10.1523/JNEUROSCI.3200-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

Review 1.  Serum autoantibodies in patients with glaucoma.

Authors:  M B Wax; J Yang; G Tezel
Journal:  J Glaucoma       Date:  2001-10       Impact factor: 2.503

2.  T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition.

Authors:  J Bauer; M Bradl; W F Hickley; S Forss-Petter; H Breitschopf; C Linington; H Wekerle; H Lassmann
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

3.  Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.

Authors:  W S Begolka; C L Vanderlugt; S M Rahbe; S D Miller
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

Review 4.  Apoptosis of inflammatory cells in immune control of the nervous system: role of glia.

Authors:  M P Pender; M J Rist
Journal:  Glia       Date:  2001-11       Impact factor: 7.452

5.  Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries.

Authors:  M Schwartz; J Kipnis
Journal:  Trends Mol Med       Date:  2001-06       Impact factor: 11.951

6.  Antiphosphatidylserine antibodies are elevated in normal tension glaucoma.

Authors:  S Kremmer; E Kreuzfelder; R Klein; N Bontke; K B Henneberg-Quester; K P Steuhl; H Grosse-Wilde
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

7.  Clinical and ocular histopathological findings in a patient with normal-pressure glaucoma.

Authors:  M B Wax; G Tezel; P D Edward
Journal:  Arch Ophthalmol       Date:  1998-08

8.  Interferon gamma immunoreactivity in iris nerve fibres during endotoxin induced uveitis in the rat.

Authors:  P Yang; A F de Vos; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

9.  Autoantibodies to small heat shock proteins in glaucoma.

Authors:  G Tezel; G M Seigel; M B Wax
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-11       Impact factor: 4.799

Review 10.  Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis.

Authors:  Monica J Carson
Journal:  Glia       Date:  2002-11       Impact factor: 8.073

View more
  87 in total

1.  Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling.

Authors:  Cheng Luo; Xiangjun Yang; Angela D Kain; David W Powell; Markus H Kuehn; Gülgün Tezel
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

Review 2.  A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma.

Authors:  Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2010-09-16       Impact factor: 3.467

3.  Expansions of the neurovascular scleral canal and contained optic nerve occur early in the hypertonic saline rat experimental glaucoma model.

Authors:  Marta Pazos; Hongli Yang; Stuart K Gardiner; William O Cepurna; Elaine C Johnson; John C Morrison; Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2015-10-22       Impact factor: 3.467

Review 4.  Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms.

Authors:  S D Crish; D J Calkins
Journal:  Neuroscience       Date:  2010-12-25       Impact factor: 3.590

5.  Differential progression of structural and functional alterations in distinct retinal ganglion cell types in a mouse model of glaucoma.

Authors:  Luca Della Santina; Denise M Inman; Caroline B Lupien; Philip J Horner; Rachel O L Wong
Journal:  J Neurosci       Date:  2013-10-30       Impact factor: 6.167

6.  Retinal gene expression changes related to IOP exposure and axonal loss in DBA/2J mice.

Authors:  Lambros Panagis; Xiujun Zhao; Yongchao Ge; Lizhen Ren; Thomas W Mittag; John Danias
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-03       Impact factor: 4.799

7.  Molecular biomarkers in glaucoma.

Authors:  Sanjoy K Bhattacharya; Richard K Lee; Franz H Grus
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

8.  Lack of immunoglobulins does not prevent C1q binding to RGC and does not alter the progression of experimental glaucoma.

Authors:  Qiong J Ding; Amy C Cook; Alina V Dumitrescu; Markus H Kuehn
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-19       Impact factor: 4.799

9.  Western blot patterns of serum autoantibodies against optic nerve antigens in dogs with goniodysgenesis-related glaucoma.

Authors:  Stephanie A Pumphrey; Stefano Pizzirani; Christopher G Pirie; M Sawkat Anwer; Tanya Logvinenko
Journal:  Am J Vet Res       Date:  2013-04       Impact factor: 1.156

10.  Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma.

Authors:  Gülgün Tezel; Ivey L Thornton; Melissa G Tong; Cheng Luo; Xiangjun Yang; Jian Cai; David W Powell; Joern B Soltau; Jeffrey M Liebmann; Robert Ritch
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.